BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15501534)

  • 1. Adrenomedullin receptors: pharmacological features and possible pathophysiological roles.
    Kuwasako K; Cao YN; Nagoshi Y; Kitamura K; Eto T
    Peptides; 2004 Nov; 25(11):2003-12. PubMed ID: 15501534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
    Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
    J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared and separate functions of the RAMP-based adrenomedullin receptors.
    Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
    Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2.
    Tam CW; Husmann K; Clark NC; Clark JE; Lazar Z; Ittner LM; Götz J; Douglas G; Grant AD; Sugden D; Poston L; Poston R; McFadzean I; Marber MS; Fischer JA; Born W; Brain SD
    Circ Res; 2006 Feb; 98(2):262-70. PubMed ID: 16373602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
    Granholm S; Lundberg P; Lerner UH
    J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor pharmacology.
    Young A
    Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
    Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
    Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.
    Cottrell GS; Roosterman D; Marvizon JC; Song B; Wick E; Pikios S; Wong H; Berthelier C; Tang Y; Sternini C; Bunnett NW; Grady EF
    J Comp Neurol; 2005 Sep; 490(3):239-55. PubMed ID: 16082677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic.
    Nishikimi T; Wang X; Akimoto K; Tadokoro K; Mori Y; Ishikawa Y; Ishimura K; Yoshihara F; Minamino N; Kangawa K; Matsuoka H
    Regul Pept; 2005 Jan; 124(1-3):89-98. PubMed ID: 15544845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CRLR/RAMP3 adrenomedullin receptor.
    Flahaut M; Pfister C; Rossier BC; Firsov D
    Biochemistry; 2003 Sep; 42(34):10333-41. PubMed ID: 12939163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
    Hay DL; Walker CS; Poyner DR
    Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
    Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
    Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
    Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.